A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

When Adam Rodman was a second-year medical student in the 2000s, he visited the library for a patient whose illness had left ...

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

Generative AI is revolutionizing various industries by enhancing creativity, automating workflows, and delivering ...

Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform.

Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

The NVIDIA BioNeMo platform provides state-of-the-art AI tools tailored for drug discovery. Its small molecule NIM ...

VANCOUVER, Wash. and NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for ...

SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Building on their longstanding partnership, NVIDIA, Alphabet and Google today announced new initiatives to advance AI, democratize access to AI ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

It's Inno Madness time! Inno Madness is our friendly, bracket-style challenge where readers vote to advance companies based ...